You are here

AI/ML Innovations Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AIML
CSE Index: 
CSE Composite
Currency: 
CAD

The Issuer is a digital health solutions provider utilizing a proprietary combination of digital health monitoring devices, AI based software, and a cloud computing platform which combine to help care givers, patients and healthcare professionals access and utilize relevant health data.

AI/ML Innovations Inc. (AIML)

(%)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Company Info

Address
#203, 645 Fort Street
Victoria, BC V8W 1G2
Canada
Email
info@aiml-innovations.com
Website
http://www.aiml-innovations.com
Listing date
Monday, January 11, 2021
Transfer Agent
Endeavor Trust Corporation
Auditor
Baker Tilly Chartered Professional Accountants WM LLP

SEDAR Information

Filing Type Any
Timeframe 1 week1 month3 month6 month1 yearAll Time

Company Info

Address
#203, 645 Fort Street
Victoria, BC V8W 1G2
Canada
Email
info@aiml-innovations.com
Website
http://www.aiml-innovations.com
Listing date
Monday, January 11, 2021
Transfer Agent
Endeavor Trust Corporation
Auditor
Baker Tilly Chartered Professional Accountants WM LLP

Capitalization

Issued & Outstanding: 
173333031
Reserved for Issuance: 
110790885

Company Officers

Paul Duffy, CEO
Mark Orsmond, Executive Chair
Peter Kendall, President & Chief Commercialization Officer
Terence Lee, Chief Financial Officer
Alan Rabinowitz, Chief Medical Officer & Director of Medical Partnerships
Esmat Naikyar, Interim Chief Product Officer
Kendra Low, Corporate Secretary
Tim Daniels, Director
Michael Nemirow, Director
Drew Dundas, Independent Director

Bulletins

08/01/2021

2021-0110 – New Listing - AI-ML Innovations Inc. (AIML)

le 8 janvier/January, 2021

The common shares of AI-ML Innovations Inc., have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.